Neuroscience
From today's Boston Globe:
-
Anthony H. Risser | neuroscience | neuropsychology | brain
- Business World: Biogen Idec, Protein Design Labs, & Daclizumab
From The Boston Globe:Biogen cuts deal to refill drug lineup Biotech to pay Calif. firm for rights to help develop MS treatment, 2 others By Jeffrey Krasner, Globe Staff The Boston Globe August 3, 2005 Making good on a promise to use a war chest of...
- Business World: Biogen Idec, Elan, & Tysabri (natalizumab)
From today's Boston Globe:Biogen MS drug gets lift from reports Medical journal suggests Tysabri may make a return By Jeffrey Krasner The Boston Globe 10 June 2005 Biogen Idec Inc.'s drug Tysabri might be safely given to multiple sclerosis patients...
- Tysabri (natalizumab): Another Case Of Pml
A third case of progressive multifocal leukoencephalopathy (PML), as reported via The New York Times website: M.S. Drug Tied to a Death Published: March 31, 2005 By Bloomberg News Biogen Idec and the Elan Corporation said that a third patient had developed...
- More M.s. Drug Woes: Avonex And 683699
Biogen and F.D.A. Issue Drug Warning By ANDREW POLLACK The New York Times Published: March 17, 2005 Biogen Idec's multiple sclerosis drug Avonex might cause severe liver damage in rare cases, the company and the Food and Drug Administration said...
- Business World: Tysabri (natalizumab) And Biogen Idec
From today's Boston Globe: Biogen Idec's top lawyer quits amid investigation By Jeffrey Krasner The Boston Globe March 10, 2005 Thomas J. Bucknum, Biogen Idec's longtime top lawyer, resigned suddenly yesterday amid an inquiry by the Securities...
Neuroscience
Business World: Biogen Idec, Elan, & Tysabri (Natalizumab)
From today's Boston Globe:
A fourth death may be tied to Biogen's MS drug[ ... Read the full article ... ]
Finding could be blow to marketplace hopes
By Jeffrey Krasner,
Boston Globe Staff
June 2, 2005
Biogen Idec Inc. has told the Food and Drug Administration that a fourth patient may have contracted a potentially deadly brain disease after being treated with the company's multiple sclerosis drug Tysabri.
-
Anthony H. Risser | neuroscience | neuropsychology | brain
- Business World: Biogen Idec, Protein Design Labs, & Daclizumab
From The Boston Globe:Biogen cuts deal to refill drug lineup Biotech to pay Calif. firm for rights to help develop MS treatment, 2 others By Jeffrey Krasner, Globe Staff The Boston Globe August 3, 2005 Making good on a promise to use a war chest of...
- Business World: Biogen Idec, Elan, & Tysabri (natalizumab)
From today's Boston Globe:Biogen MS drug gets lift from reports Medical journal suggests Tysabri may make a return By Jeffrey Krasner The Boston Globe 10 June 2005 Biogen Idec Inc.'s drug Tysabri might be safely given to multiple sclerosis patients...
- Tysabri (natalizumab): Another Case Of Pml
A third case of progressive multifocal leukoencephalopathy (PML), as reported via The New York Times website: M.S. Drug Tied to a Death Published: March 31, 2005 By Bloomberg News Biogen Idec and the Elan Corporation said that a third patient had developed...
- More M.s. Drug Woes: Avonex And 683699
Biogen and F.D.A. Issue Drug Warning By ANDREW POLLACK The New York Times Published: March 17, 2005 Biogen Idec's multiple sclerosis drug Avonex might cause severe liver damage in rare cases, the company and the Food and Drug Administration said...
- Business World: Tysabri (natalizumab) And Biogen Idec
From today's Boston Globe: Biogen Idec's top lawyer quits amid investigation By Jeffrey Krasner The Boston Globe March 10, 2005 Thomas J. Bucknum, Biogen Idec's longtime top lawyer, resigned suddenly yesterday amid an inquiry by the Securities...